Select a community
All Communities
Home > Community Treatment Reports > Ebixa (memantine) Treatment Report
What is Ebixa?

Brand name for the drug memantine which is the first in a novel class of Alzheimer's disease medications acting on the glutamatergic system. It is also being tested for use as a cognitive enhancer in a variety of other conditions. Read more...Click to read more below

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Other 2 0

Mouse over the table for more information

Dosages

  10 mg daily 20 mg daily
  1 Number of Patients: 1 3 Number of Patients: 3  

Duration See details about how long patients take this treatment ▼

Currently Taking Ebixa

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
1
0
0
0
1

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
0 0%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
0 0%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
0 0%

Report created on November 22, 2009.